Panasonic, the leading brand by which Matsushita Electric Industrial Co., Ltd. is known, in collaboration with Professor Naoki Sugimoto of Konan University, has developed a technology for electrically identifying single nucleotide polymorphisms, or SNPs[1] (sequence variations in DNA[2]). This world-first technology* provides economical and accurate identification of SNPs by measuring electrical current without attaching DNA to electrodes.
This technology makes it possible to predict individuals' responses to drugs and their risk of developing disease. In the future, this technology is expected to enable hospitals or clinics to provide patients with treatments and drugs tailored to their individual physical characteristics. With this new technology, Panasonic is contributing to a more personalized medical treatment based on the patient's DNA sequence.
http://panasonic.co.jp/corp/news/official.data/data.dir/en080819-2/en080819-2.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment